Radioiodine and pregnancy

The fetal thyroid begins to accumulate radioiodine around the 12th week of pregnancy. Iodide easily crosses the placenta and fetal thyroid uptake can be effectively blocked by administration of radioiodine to the mother. Ther apeutic administration of radioiodine to the mother will usually result in fetal hypothyroidism and may be associated with attention deficit disorders and impairment of figurative memory in the offspring. The hazard to a fetu s from exposure to a family member, not the mother, who has been treated wi th radioiodine is very small and can be minimized by adherence to standard post treatment guidelines. Lactating mothers who have received standard dia gnostic doses of I-131 or who have been treated with I-131 should not breas t-feed their infant from that point forward. Breast-feeding in future pregn ancies is not contraindicated. Pregnancy testing within 48 hours before I-1 31 administration to potentially fertile women is a wise clinical practice. Demonstrated effects of radioiodine on spermatogenesis suggest that it is wise to recommend a 120-day waiting period between radioiodine and fertiliz ation.